Aug 25, 2016

Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease | Aug 01, 2016 | JAMA Internal Medicine | JAMA Network

This secondary analysis of a randomized clinical trial assesses the effect of pharmacologic therapy and clinical risk factors on incident conduction system disease in patients with hypertension.

Proceed to the page: http://linkis.com/GZhCY

Similar Articles Added Earlier

Similar Articles Added Today

Latest Links Processed

0/120